Senior Director, Oncology Policy and Advocacy (Washington, DC or Cambridge, MA)
bluebird bio – Washington, DC
Position Summary: Position is charged with anticipating and prospectively developing opportunities for bluebird in oncology policy; commits to building and maintaining relationships with Cambridge-based bluebirds (including dedicated routine time spent in person) to ensure healthcare economics, and federal and state coverage and reimbursement projects are effectively managed; and shaping a positive business and public policy environment for bluebird s developing oncology portfolio. Of critical importance will be the need to develop and leverage relationships with key thought leaders to further bluebird s business opportunities and business plans and continuously develop and coordinate strategic alliance development programs.
- Work cross-functionally and with external bluebird development/commercialization partners to develop and implement strategies to obtain timely coverage and reimbursement for bluebird s approved cellular and gene therapies in the oncology franchise, with a focus on public payers (e.g., Medicare, Medicaid). This includes but is not limited to:
- Establishing and executing on policy priorities to meet the bluebird s critical business needs;
- Leveraging in-depth knowledge of public payer coverage, coding, and reimbursement policies to create approaches and tools to address these needs; and
- Leveraging an in-depth understanding of the organization to build credibility and acceptance with bluebird s priorities among internal and external stakeholders and audiences.
- Shape the external policy environment to support patient access to approved bluebird therapies in the oncology space, to include cultivating and maintaining relationships with appropriate / relevant federal and state policymaker, payer, and other relevant audiences (e.g., bluebird centers of excellence, patient and provider advocacy organizations). This includes but is not limited to:
- Leading development of bluebird public comments with input from the cross-functional business
- Partnering with Government Affairs to shape messaging with public payer engagement on coding, coverage, and reimbursement initiatives, including developing/submitting coding requests
- Coordinate with bluebird program teams, commercial operations, market access, patient advocacy, and all other relevant functions to align and incorporate in-line product strategies and pipeline into policy objectives (includes participation in commercial teams and other related meetings).
- Serving as the lead for communicating the impact of developments within oncology healthcare policy and the oncology regulatory landscape to bbb program teams and driving policy creation/strategy and implementation.
- In coordination with internal businesses (e.g., Access, Value, and Evidence Strategy) utilize and leverage the need to create compelling health care economics data and evidence to support increased access and favored reimbursement products. This includes but is not limited to:
- Leading on development of bluebird comments with input from the cross-functional business on value organizations review methodologies/frameworks
- Represent bluebird in relevant coalition and trade associations and public sector payer/policy committees, driving public policy matters internally and externally
Required Skills and Experience:
- Bachelor s degree required
- JD, MBA or Master of Public Policy desirable
- Must have oncology-specific biopharmaceutical business knowledge
- Must have federal and state policy and reimbursement experience, and exhibit strategic thinking.
- Ten (10) + years business experience in reimbursement/government affairs development is required
- Specific experience on cell therapy (e.g., CAR T-cell therapy) US public policy and payer issues preferred
- Project management, public policy experience with government programs and managed markets experience is highly desirable
- Managerial experience and budget management desirable
- Lobbying experience desirable
- Work Environment: Office with approximately 30 40 % U.S. travel required
- May be based in either Washington, DC or Cambridge, MA